|
ABOUT COMPANY
Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.
|
EARNINGS
Gross Profit (TTM): 133438000
Market Capitalization: 2521049000
Operating Margin (TTM): -4.423
PE Ratio: None
PEG Ratio: 3.22
Profit Margin: 0
Revenue Per Share (TTM): 0.551
Revenue (TTM): 100360000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.17
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.723
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -418699008
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|